Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Molecular Imaging and Biology|July 9, 2026
Automated cGMP Radiosynthesis of [<sup>18</sup>F]NOTA-ABY-030 with Aluminum Fluoride on the GE FASTlab Automated Synthesis PlatformWilliam Behof, Imtiaz Khan, Julian Grigg, et al.
Molecules (Basel, Switzerland)|April 30, 2021
Design, Synthesis, and Validation of a Novel [<sup>11</sup>C]Promethazine PET Probe for Imaging Abeta Using AutoradiographyClayton A Whitmore, Mariam I Boules, William J Behof, et al.
Head & Neck|May 25, 2026
Visualization of Scattered Tumor Regression Following Neoadjuvant Chemoimmunotherapy With a Novel Intraoperative PET/CT ScannerAndreja Radevic, Joaquin Austerlitz, Ashtyn McAdoo, et al.
Scientific Reports|September 17, 2021
A novel antioxidant ergothioneine PET radioligand for in vivo imaging applicationsWilliam J Behof, Clayton A Whitmore, Justin R Haynes, et al.
Theranostics|February 16, 2026
Use of Dual-Modality Antibody Imaging for Assessment of Lymph Node Metastases in Head and Neck CancerNicole Meeks, Ashtyn G McAdoo, Yu-Jin Lee, et al.
Head & Neck|June 17, 2026
Early Feasibility of Registration of Micro-PET/CT Scans to Annotated 3D Specimen ModelsJoaquin Austerlitz, Andreja Radevic, Ashtyn McAdoo, et al.
FEBS Letters|January 31, 2022
Improved synthesis of an ergothioneine PET radioligand for imaging oxidative stress in Alzheimer's diseaseWilliam J Behof, Clayton A Whitmore, Justin R Haynes, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 7, 2025
Brain cholinergic terminal density utilizing [<sup>18</sup>F]-fluoroethoxybenzovesamicol PET in adults with Down's syndrome: Relationship to amyloid PET and cognitive performanceJason K Russell, Alexander C Conley, Brian D Boyd, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersJason K Russell, Alexander C Conley, Brian Boyd, et al.
Neurobiology of Aging|February 6, 2025
Differences in cholinergic terminal density in adults with Down syndrome compared to neurotypical controls measured by [<sup>18</sup>F]-fluoroethoxybenzovesamicol positron emission tomography imagingJason K Russell, Alexander C Conley, Brian D Boyd, et al.
Pageof 4